Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Del Labs

This article was originally published in The Tan Sheet

Executive Summary

Del Labs: Strong year-end results "enable the company to evaluate and move quickly" on future acquisitions, Del says Feb. 10. Net sales for the year ended Dec. 31 increased 12.9% to $263 mil., and earnings jumped 41.5% to $13.1 mil. Sales were "particularly strong" in its cosmetics business, the company notes. For the fourth quarter, sales rose 10.9% to $64.8 mil., while earnings grew 40% to nearly $3 mil. The firm attributes its record earnings levels to increased revenues, effective cost control and increased efficiency, as well as the ability to make necessary investments in technology, including computer ordering, invoicing and rapid inventory replenishment...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS088084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel